Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217.
Wojdała AL, Vanbrabant J, Bayoumy S, Antwi-Berko D, Bastard NL, van der Flier WM, Jeromin A, Lambrechts C, Van Loo M, Vandijck M, Stoops E, Verberk IMW, Teunissen CE. Wojdała AL, et al. Among authors: verberk imw. Alzheimers Res Ther. 2024 Dec 19;16(1):266. doi: 10.1186/s13195-024-01630-5. Alzheimers Res Ther. 2024. PMID: 39702308 Free PMC article.
Performance of plasma p-tau217 and NfL in an unselected memory clinic setting.
Rousset RZ, Claessen T, van Harten AC, Lemstra AW, Pijnenburg YAL, van der Flier WM, den Braber A, Jeromin A, Verberk IMW, Teunissen CE. Rousset RZ, et al. Among authors: verberk imw. Alzheimers Dement (Amst). 2024 Nov 23;16(4):e70003. doi: 10.1002/dad2.70003. eCollection 2024 Oct-Dec. Alzheimers Dement (Amst). 2024. PMID: 39583647 Free PMC article.
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals.
Del Campo M, Quesada C, Vermunt L, Peeters CFW, Hok-A-Hin YS, Trieu C, Braber AD, Verberk IMW, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE. Del Campo M, et al. Among authors: verberk imw. Mol Neurodegener. 2024 Nov 11;19(1):82. doi: 10.1186/s13024-024-00767-z. Mol Neurodegener. 2024. PMID: 39523360 Free PMC article.
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.
Bader I, Groot C, Tan HS, Milongo JA, Haan JD, Verberk IMW, Yong K, Orellina J, Campbell S, Wilson D, van Harten AC, Kok PHB, van der Flier WM, Pijnenburg YAL, Barkhof F, van de Giessen E, Teunissen CE, Bouwman FH, Ossenkoppele R. Bader I, et al. Among authors: verberk imw. Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1. Alzheimers Res Ther. 2024. PMID: 39169442 Free PMC article.
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice.
Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C, Marizzoni M, van de Giessen EM, Lemstra AW, Pijnenburg YAL, van der Flier WM, den Braber A, Wilson D, Schut MC, van Harten AC, Teunissen CE. Verberk IMW, et al. Alzheimers Dement. 2024 Sep;20(9):6115-6132. doi: 10.1002/alz.14088. Epub 2024 Aug 3. Alzheimers Dement. 2024. PMID: 39096164 Free PMC article.
Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer's disease and a history of traumatic brain injury.
van Amerongen S, Das S, Kamps S, Goossens J, Bongers B, Pijnenburg YAL, Vanmechelen E, Vijverberg EGB, Teunissen CE, Verberk IMW. van Amerongen S, et al. Among authors: verberk imw. Neurobiol Aging. 2024 Sep;141:121-128. doi: 10.1016/j.neurobiolaging.2024.06.001. Epub 2024 Jun 14. Neurobiol Aging. 2024. PMID: 38908030 Free article.
57 results